Vizient Pharmacy Network Meeting

Las Vegas, NV US
December 3, 2022

The activity will provide participants with knowledge, approaches, and ideas related to well-being, leadership, communication, technology, pharmacy practice, and pharmacy operations. The knowledge, approaches, and ideas should be used by participants to compare to their individual practice sites and develop an action plan to improve their practices. Additionally, the activity will encourage networking to develop relationships that can be used during and after the meeting to share experiences and provide mentorship in completion of action plans.

Target Audience

This activity is intended for pharmacist and pharmacy technicians. 

Learning Objectives

Pharmacists learning objectives

At the conclusion of this activity, pharmacist should be able to:

  • Identify disruptive innovation impacting healthcare and pharmacy.
  • Review opportunities to advance resident practice standards.
  • Review strategies to address new pharmacy challenges in clinical practice.
  • Describe opportunities for pharmacists to improve patient care.
  • Develop new strategies for medication cost savings initiatives.
  • Review opportunities to optimize pharmacy operations practices.

 

Pharmacy technician learning objectives

At the conclusion of this activity, pharmacy technicians should be able to:

  • Review administration opportunities for technicians to advance pharmacy technician practice
  • Develop strategies to optimize patient safety.
  • Develop strategies to optimize medication management.

Additional Information

Course summary
Available credit: 
  • 4.50 ACPE Pharmacist
  • 4.50 ACPE Pharmacy Technician
Course opens: 
12/03/2022
Course expires: 
01/17/2023
Event starts: 
12/03/2022 - 9:15am CST
Event ends: 
12/03/2022 - 3:30pm CST
Mandalay Bay
3950 S. Las Vegas Blvd
Las Vegas, NV 89119
United States

Faculty
Adam Ewald, PharmD, MHA
Sr. Pharmaceutical Contract Portfolio Manager
Mayo Clinic Health System 

Akwi Aseh, BSN, RN-BC
ERAS Nurse Coordinator
Baptist Memorial Hospital-Memphis 

Al Ochlak, RPh, MS
Administrative Director of Pharmacy Services
Cooper University Health System 

Andrea Kliss, MA, CPPS, CPHQ
System Director of Quality
Nuvance Health

Andy Kieszkowski, PharmD
Pharmacist Team Lead
Indiana University Health Arnett Hospital 

Ann Cabri, PharmD
Specialist, Med Use Systems & Clinical Informatics
UC Davis Health

Anthony Boyd, PharmD, BCPS
Director of Pharmacy, Oncology Services
Cleveland Clinic

Ashley Street, PharmD, MSHA
Assistant Director of Pharmacy, Adult Clinical Services & Education
WVU Medicine – WVU Hospitals 

Bree Meinzer, PharmD, BCACP, CACP
Managed Care Manager
University of Toledo Medical Center 

Brittany Lee Karas, PharmD, BCPS
Medication-Use Policy Pharmacist
Northwestern Memorial Hospital 

Carrie Krekeler, PharmD, BCGP
Pharmacy Manager
IU Health Arnett 

Christopher Campbell, PharmD, BCPPS
Pediatric Clinical Pharmacist
Augusta University

Colleen M. Malashock, PharmD, BCPS, DPLA
Inpatient Pharmacy Clinical Manager
Nebraska Medicine

Craig Reha, PharmD, BCPS
Pharmacy Clinical Informatics Lead
Nebraska Medicine

Darlene Tat, PharmD, MPHc
Clinical Pharmacist
Rhode Island Hospital, Lifespan 

David George, RPh, MBA
Administrative Director, Pharmacy; Clinical Nutrition & Disease Management
Arnett, White Memorial, Frankfort Hospital  

Domini Hood, PharmD
Medication Safety Officer
UC Davis Health

Elise Dasinger, PharmD, MHA
Opioid Stewardship Pharmacist
UAB Hospital 

Elizabeth Mills, PharmD, BCPS
Lead Clinical Pharmacy Specialist
Baptist Memorial Hospital-Memphis 

Erin Meilton, PharmD, BCPS
Site Manager, Ambulatory Pharmacy Services
OhioHealth

Fatma H. Osman, PharmD, MHA
Inpatient Pharmacy Manager
UC Davis Health

Glenn Kuz, PharmD, CMMT
Pharmacist II
UW Medicine

Hannah Trickett, PharmD, BCPS
Lead Medication Use Clinical Specialist
WVU Medicine Health System 

Holly Smith, RPh, MBA
Pharmacy Director, Ambulatory Care
University of Toledo Medical Center 

Hubert Tse, PharmD, BCPS
Clinical Program Manager
Memorial Hermann Health System 

Jocelyn Keehner, MD
Assistant Professor Clinical Series
UCSF

John Folstad, PharmD, BCPS
Pharmacy Operations Manager
Mayo Clinic Health System – Eau Claire

Jordan V. DeWitt, PharmD, BCPS, BCCCP
Medical ICU Pharmacist, PGY1 Pharmacy Residency Program Director
OhioHealth Riverside Methodist Hospital 

Joshua D Villarreal, PharmD, MPA, BCPS
Lead Clinical Educator
University of Washington Medical Center 

Karen Williams, PharmD, BCPPS
Pediatric Clinical Pharmacy Specialist
Children’s Memorial Hermann Hospital

Kristin Hanson, BSPharm, MS
Medication Safety Officer
Froedtert & the Medical College of Wisconsin

Kristin Held Wheatley, PharmD, BCOP
Clinical Pharmacy Specialist, Pediatric Oncology and Infectious Diseases/Program Director, PGY1 Pharmacy Residency
Lehigh Valley Health Network

Laura Certain, MD, PhD
Assistant Professor
University of Utah 

Laura Leal, MSN, RN, CNL
Opioid Stewardship Manager
UAB Hospital

Lauren Endriukaitis, PharmD, BCPS
Medication Use Policy Pharmacist
Northwestern Memorial Hospital 

Louis Palmisciano, BS
Information Systems
Manager, Outcomes and Impact, Pharmacy
Lifespan 

Mackenzie Welsh, PharmD
Lead Pain Management and Palliative Care Pharmacist
University of Washington Medicine

Mark E. Greg, PharmD, RPh
Program Director - Ambulatory Pharmacy
Northwestern Medicine 

Matthew Jenkins, PharmD, MS
Senior Director, Pharmacy Services
University of Virginia (UVA) Health

Michael Poirier, PharmD
System Director, Pharmacy Ambulatory Care Services
Lifespan 

Mikyung (M.K.) Choe, PharmD, BCOP
Clinical Pharmacy Specialist– Hematology/ Oncology
Vassar Brothers Medical Center (Dyson Center for Cancer Care)

Molly Leber, PharmD, MBA, BCPS, FASHP
Associate Director, Drug Use Policy and Formulary Management
Yale New Haven Health

Molly Wheeler, PharmD, BCPS
Abdominal Solid Organ Transplant & Immunocompromised ICU Clinical Pharmacist
Mayo Clinic – Rochester

Rita Shane, PharmD, FASHP, FCSHP
Vice President and Chief Pharmacy Officer
Cedars-Sinai Medical Center 

Riti Gupta, PharmD, BCPS, CDCES
Ambulatory Care Clinical Pharmacist
Stanford Health Care 

Ruchik Patel, PharmD
Business Coordinator- Specialty Pharmacy Services / Clinical Assistant Professor
University of Illinois Hospital & Health Sciences System

Russell Benefield, PharmD, BCPS-AQ ID
Clinical Coordinator, Infectious Disease
University of Utah Health 

Sarah Chong, PharmD
PGY-2 Pharmacy Resident 
University of Maryland Medical Center 

Susan M. Flaker, PharmD, MBA, DPLA
Regional Director of Pharmacy
Mayo Clinic Health System 

Taylor Mancuso, PharmD
Medication Safety Pharmacist
Froedtert & the Medical College of Wisconsin 

Thanh Tu, PharmD, BCPS
Program Coordinator – Pharmacy Enterprise
Cedars-Sinai Medical Center 

Planning Committee 
Rebecca Pettit, PharmD, MBA, BCPS, BCPPS, FCCP
Pediatric Pulmonary Clinical Pharmacy
Program Director, Pediatric PGY2 Residency
Riley Hospital for Children, Indiana University Health

Pooja Shah, PharmD, BCPS, 340B ACE
Pharmacy Manager, 340B Programs
UNC Health

Sybil Thomas, PharmD, MBA
Associate Vice President, Member Connections
Pharmacy/Imaging/Laboratory/Respiratory Network
Vizient, Inc.

 

Identification, Mitigation, and Disclosure of Relevant Financial Relationships

As an accredited provider of continuing education, Vizient, Inc. is dedicated to ensuring this activity presents learners with only accurate, balanced, scientifically justified recommendations, and is free from promotion, marketing, and commercial bias. In accordance with The Standards for Integrity and Independence in Accredited Continuing Education, all planners, faculty, and others in control of the educational content have disclosed the absence or existence of all financial relationships (of any dollar amount) with ineligible companies within the past 24 months.

It is Vizient’s policy that owners and employees of ineligible companies, and any individuals who refuse to disclose the absence or existence of financial relationships with any ineligible companies are disqualified from participating as planners or faculty.

Disclosure of Relevant Financial Relationships:

Relevant Financial Relationships 

Vizient, Inc., Jointly Accredited for Interprofessional Continuing Education, defines companies to be ineligible as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

An individual is considered to have a relevant financial relationship if the educational content an individual can control is related to the business lines or products of the ineligible company.

Anthony Boyd, PharmD, BCPS, speaker for this educational activity, is on the Advisory Board for Baxter International, Bristol Myers Squibb (BMS), Fresenius Kabi, Regeneron Pharmaceuticals, and TerSera Therapeutics.

John Folstad, PharmD, BCPS, speaker for this educational activity, is employed by an organization that has minority ownership in PharmAdva, LLC.

Russell Benefield, speaker for this educational activity, is an Investigator-Initiated Research Grant for Paratek Pharmaceuticals.

All relevant financial relationships listed for these individual(s) have been mitigated.

All others in a position to control content for this educational activity have no relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Statement of Content Validity

Vizient, Inc. educational activities are intended to assist healthcare teams advance their professional responsibilities in accordance with the definition of continuing education. It is the policy of Vizient, Inc. to review and ensure that all content and recommendations for patient care within accredited CE is evidenced-based, based on current science and clinical reasoning while ensuring the content is fair and balanced. All recommendations must conform to the generally accepted standards of experimental design, data collection, analysis, and interpretation. Vizient, Inc. does not permit accredited continuing education if it advocates for unscientific approaches to diagnosis or therapy, or if the education promotes recommendations, treatment, or manners of practicing healthcare that are determined to have risks or dangers that outweigh the benefits or are known to be ineffective in the treatment of patients.

FDA off-label/unapproved usage

Faculty/Presenters are required to identify any new and evolving topics for which there is a lower/absence of evidence base. This is to ensure that our content does not advocate for, or promote, practices that are not, or not yet adequately based on current science, evidence, and clinical reasoning. Faculty/Presenters are required to disclose any discussion of (1) off-label/unapproved or investigational uses of FDA approved commercial products or devices and/or (2) products or devices not yet approved in the United States.

Usage Disclosure: “Off-label/unapproved drug uses or products are mentioned within this activity.

Evidence-based Content: Low/absence of evidence-based topics are mentioned within this activity

Disclaimer: The education provided through this activity is for continuing education purposes only. The views and opinions expressed in this activity are those of the faculty/presenters and do not necessarily reflect the views of Vizient, Inc.

In support of improving patient care, Vizient, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

 

 

Designation Statement:

PHARMACY

Vizient, Inc. designates this activity for a maximum of 4.5 ACPE credit hours.

Universal Activity Number: JA0006103-0000/9999-22-TBD-L01-P (change to correct area of pharmacy study)

Universal Activity Number: JA0006103-0000/9999-22-TBD-L01-T (change to correct area of pharmacy study)

Available Credit

  • 4.50 ACPE Pharmacist
  • 4.50 ACPE Pharmacy Technician
Please login or register to take this course.